Hansen KE et al. Arch Intern Med 2005; 165:2671-2676.

Patient variable Results

Mean duration of statin therapy before myopathy (mo)

6.3

Mean duration of myalgia after stopping statin therapy (mo)

2.3

Rhabdomyolysis, n (%) 8 (18)

Hospitalization, n (%) 6 (13)

Renal dysfunction

• Temporary, n (%) 2 (4)

• Permanent, n (%) 1 (2)

Received another statin, n (%) 37 (82)

Recurrent muscle pain, n (%) 21 (57)

No recurrent muscle pain, n (%) 16 (43)

Long-term outcome in 45 patients with statin-associated myopathy